Vijay Pande, founding partner of a16z bio and health strategy, steps down

Vijay Pandey, general partner of Andresen Horovits, who founded the firm’s A1 16 Z Bio+ Health Strategy, Declaration That he is moving away from his role.

Since its inception in 20, A1 16J Bio+ Health has raised about $ 4 billion funds, including $ 1.5 billion funds that were closed in 2022. However it is looking very small now 50 750 million fifth fundWall Street has reported the journal. In January, A1 16 Z Bio+ Health declared that it would handle it $ 500 million biotek funds Pharmaceutical giant Eli is meaningful by Lily.

A1 16 Z Bio + Health Backs Digital Health Startups and Organizations at Counting and Biology.

Pandey’s investment includes dedicated health, a distinct treatment plan supplier; Function Health, a personalized lab testing startup; And a company called Frinome is aiming to detect cancer through blood drawing. Prior to joining Andresen Harovits, Pandey was a professor of chemistry, structural biology and computer science at Stanford University.

The rest of the A16z Bio + Health team partners are George Conde, Julie Yu and Vainita Agarwala.